These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19609527)

  • 1. Two cases of distal extremity swelling with pitting oedema in psoriatic arthritis: the different pathological mechanisms.
    Quarta L; Corrado A; d'Onofrio F; Maruotti N; Cantatore FP
    Rheumatol Int; 2010 Aug; 30(10):1367-70. PubMed ID: 19609527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distal extremity swelling with pitting edema in psoriatic arthritis: evidence of 2 pathological mechanisms.
    Salvarani C; Cantini F; Olivieri I; Niccoli L; Senesi C; Macchioni L; Boiardi L; Padula A
    J Rheumatol; 1999 Aug; 26(8):1831-4. PubMed ID: 10451085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distal extremity swelling with pitting oedema in rheumatoid arthritis.
    Paira S; Caliani L; Luraquiz N
    Clin Rheumatol; 2001; 20(1):76-9. PubMed ID: 11254249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of etanercept in lymphedema associated with psoriatic arthritis.
    Lekpa FK; Economu-Dubosc A; Fevre C; Claudepierre P; Chevalier X
    J Rheumatol; 2009 Jan; 36(1):207-8. PubMed ID: 19208540
    [No Abstract]   [Full Text] [Related]  

  • 5. Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy.
    Iyer S; Yamauchi P; Lowe NJ
    Br J Dermatol; 2002 Jan; 146(1):118-21. PubMed ID: 11841377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary study of etanercept in the treatment of severe, resistant psoriatic arthritis.
    Yazici Y; Erkan D; Lockshin MD
    Clin Exp Rheumatol; 2000; 18(6):732-4. PubMed ID: 11138337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of clinical efficacy of tumor necrosis factor‑α inhibitors in treatment of distal extremity swelling with pitting edema in psoriatic arthritis of inadequate response to conventional therapy: A 10‑year retrospective study.
    Zhao C; Liu B; Yao Y; Yang K; Zang B; Liu B
    Exp Ther Med; 2023 Jun; 25(6):263. PubMed ID: 37206568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept plus ciclosporin versus etanercept plus methotrexate for maintaining clinical control over psoriatic arthritis: a randomised pilot study.
    Atzeni F; Boccassini L; Antivalle M; Salaffi F; Sarzi-Puttini P
    Ann Rheum Dis; 2011 Apr; 70(4):712-4. PubMed ID: 20810394
    [No Abstract]   [Full Text] [Related]  

  • 9. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR; Keating GM
    Drugs; 2002; 62(17):2493-537. PubMed ID: 12421111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors.
    Mease PJ
    Ann Rheum Dis; 2002 Apr; 61(4):298-304. PubMed ID: 11874829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis.
    Anandarajah AP; Schwarz EM; Totterman S; Monu J; Feng CY; Shao T; Haas-Smith SA; Ritchlin CT
    Ann Rheum Dis; 2008 Mar; 67(3):296-301. PubMed ID: 17967829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis.
    Bansback NJ; Ara R; Barkham N; Brennan A; Fraser AD; Conway P; Reynolds A; Emery P
    Rheumatology (Oxford); 2006 Aug; 45(8):1029-38. PubMed ID: 16782734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etanercept (Enbrel) -- an update.
    Goffe B
    Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):1-4, 9. PubMed ID: 15657632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
    Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
    J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
    [No Abstract]   [Full Text] [Related]  

  • 15. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
    Alivernini S; Tolusso B; Petricca L; Bui L; Di Sante G; Peluso G; Benvenuto R; Fedele AL; Federico F; Ferraccioli G; Gremese E
    Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of psoriatic arthritis and recalcitrant skin disease with combination therapy.
    Hamilton TK
    J Drugs Dermatol; 2008 Nov; 7(11):1089-93. PubMed ID: 19110745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriatic arthritis and chronic lymphoedema: treatment efficacy by adalimumab.
    Tong D; Eather S; Manolios N
    Clin Rheumatol; 2009 Nov; 28(11):1349-50. PubMed ID: 19693641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational study.
    de Vlam K; Lories RJ
    Rheumatology (Oxford); 2006 Mar; 45(3):321-4. PubMed ID: 16234275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of idiopathic recurrent pericarditis in a psoriatic arthritis patient treated with etanercept.
    Esposito M; Giunta A; Babino G; Schipani C; Marchei M; Chimenti MS
    Eur J Dermatol; 2012; 22(1):151-2. PubMed ID: 22155373
    [No Abstract]   [Full Text] [Related]  

  • 20. Etanercept is safely used for treating psoriatic arthritis in a patient complicated with type 1 hereditary angioedema.
    Umegaki N; Kira M; Horiuchi T; Itoi S; Tani M; Yokomi A; Tanemura A; Miyahara H; Hatanaka M; Kitamura H; Kitano E; Katayama I
    Mod Rheumatol; 2012 Nov; 22(6):928-30. PubMed ID: 22310967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.